Supporting New Superbug Drugs: Better Infection Treatment
This act aims to accelerate the development of new drugs to combat dangerous bacterial infections resistant to current antibiotics. Through this program, citizens can expect access to more effective therapies for hard-to-treat diseases, improving their health security and reducing the risk of complications.
Key points
Establishes a financial support program for companies developing innovative antimicrobial drugs, especially those targeting drug-resistant infections.
Creates an expert committee and advisory group to identify the most urgent needs for new drugs and define their desired characteristics.
Introduces a "subscription" system for new drugs, meaning the government will pay a fixed amount for drug access regardless of doses sold, encouraging research investment.
Requires drug manufacturers to monitor and publicly report drug resistance data and develop educational strategies for patients and healthcare professionals.
Provides a grant program for hospitals to improve appropriate antibiotic use and resistance monitoring, aiming to limit superbug spread.
Expired
Citizen Poll